Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $24 | $28 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $36 | $20 | $55 | $24 |
| Inventory | $48 | $49 | $50 | $48 |
| Other Curr. Assets | $0 | $0 | $8 | $24 |
| Total Curr. Assets | $93 | $93 | $146 | $102 |
| Property Plant & Equip (Net) | $51 | $102 | $106 | $107 |
| Goodwill | $5 | $5 | $5 | $5 |
| Intangibles | $109 | $142 | $140 | $120 |
| Long-Term Investments | $16 | $12 | $24 | $30 |
| Tax Assets | $0 | $16 | $16 | $65 |
| Other NC Assets | $12 | $5 | $4 | $3 |
| Total NC Assets | $193 | $282 | $297 | $331 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $287 | $375 | $442 | $433 |
| Liabilities | – | – | – | – |
| Payables | $59 | $45 | $32 | $28 |
| Short-Term Debt | $27 | $36 | $65 | $89 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $1 | $1 | $2 |
| Other Curr. Liab. | $0 | $1 | $20 | $3 |
| Total Curr. Liab. | $104 | $89 | $130 | $127 |
| LT Debt | $148 | $146 | $138 | $126 |
| Deferred Rev, NC | $0 | $19 | $8 | $12 |
| Deferred Tax Liab, NC | $0 | $4 | $4 | $5 |
| Other NC Liab. | $107 | $91 | $90 | $87 |
| Total NC Liab. | $286 | $294 | $278 | $269 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $32 | $34 | $38 | $40 |
| Total Liabilities | $390 | $383 | $409 | $396 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $51 | $43 | $41 | $37 |
| Retained Earnings | -$589 | -$465 | -$396 | -$368 |
| AOCI | $11 | -$0 | -$20 | -$18 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$103 | -$9 | $34 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $287 | $375 | $442 | $432 |
| Net Debt | $165 | $159 | $174 | $185 |